Malcolm Anastasius1, MBBS, PhD; Marcelo Godoy1, MD; Jonathan R. Weir-McCall2, MBChB, PhD; Vinayak Bapat3, MBChB, MPH; Janarthanan Sathananthan1, MB, DCH, BAO; Mark Hensey1, PhD; Stephanie L. Sellers4, MD; Anson Cheung1; Jian Ye1, MD; David A. Wood1, MD; Jonathon Leipsic1, MD, FSCCT; John Webb1, MD; Philipp Blanke1, MD, FSCCT
1. Center for Heart Valve Innovation, St. Paul’s Hospital and University of British Columbia, Vancouver, BC, Canada; 2. Department of Radiology, University of Cambridge, Papworth Hospital, Cambridge, United Kingdom; 3. Division of Cardiology, New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY, USA; 4. Centre for Heart Lung Innovation and Department of Radiology, University of British Columbia and St. Paul’s Hospital, Vancouver, BC, Canada
Aortic valve-in-valve (aVIV) procedures are advancing the management of failed bioprosthetic surgical heart valves (SHV)1,2. As opposed to transcatheter heart valve (THV) replacement for native aortic stenosis, selection of the transcatheter THV size for aVIV procedures is based on the SHV size and not on anatomical measurements. However, accurate SHV size information may not be available in medical records. While computed tomography (CT) may be used to derive dimensions of the SHV, it does have limitations3. The aim of this study was to establish reference data for CT dimensions across commonly used aortic stented SHV types and ...
No account yet? Create my pcr account
Sign up for free!
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases
Interventions for valvular diseaseOther valvular and structural interventions
Read next article
A pilot study with the TriGUARD 3 cerebral embolic protection device